328 results
Page 11 of 17
8-K
EX-99.1
m3rt4wyxwy h3fgwe9
2 Apr 12
Program Committee Recognizes Presentation as Among the Best Science at AACR
12:00am
8-K
EX-99.1
977isb nn
2 Apr 12
ZIOPHARM Oncology Provides Update on PICASSO 3 Trial
12:00am
8-K
EX-99.1
u4kof72
29 Feb 12
ZIOPHARM Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
8-K
EX-99.1
mcfm0lynio2nbzbv2yr8
14 Feb 12
ZIOPHARM Oncology Reports Positive Preliminary Palifosfamide Overall Survival Data from Randomized Phase 2 Study in Soft Tissue Sarcoma
12:00am
8-K
EX-1.1
gbmg 7qfz
25 Jan 12
ZIOPHARM Oncology Prices Public Offering of Common Stock
12:00am
8-K
EX-99.1
mwsjo2viy1t at4onzw
25 Jan 12
ZIOPHARM Oncology Prices Public Offering of Common Stock
12:00am
424B5
p1wd3bad79 nnas
23 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
9jkkyd1lg
20 Jan 12
ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock
12:00am
424B5
umswsjz79h3g7r ej
19 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
57ezz ohf29h
7 Dec 11
ZIOPHARM Granted European Patent Allowance for Palifosfamide
12:00am
8-K
EX-99.1
fjfzmgtcsuj
3 Nov 11
ZIOPHARM Reports Third Quarter Financial Results and Highlights
12:00am
8-K
EX-10.1
nlvm9h3 ojqhuprx
6 Sep 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
69557xw 5ch
1 Aug 11
ZIOPHARM Reports Second Quarter Financial Results and Highlights
12:00am
8-K
EX-10.1
7doqrv28cin
15 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
3i6wzoyqbd3yjtef9c
10 Jun 11
Other Events
12:00am
8-K
EX-99.1
4lw36dat7kx8lgq7pj
6 Jun 11
Other Events
12:00am
8-K
EX-10.1
ppk3k y05vsz8jcal
3 Jun 11
Departure of Directors or Certain Officers
12:00am